GSK adds EU to Blenrep checklist as FDA sets new PDUFA date

GSK has added the EMA to the list of regulatory bodies approving Blenrep for multiple myeloma, but whether the FDA is next is still an open question.

How will NICE fare in a post-Brexit world?

NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU?

Coronavirus could threaten US drug supplies - report

About 150 prescription drugs, including antibiotics, generics and some branded drugs without alternatives, could be at risk of shortage if the COVID-19 coronavirus outbreak worsens accordin

EMA cuts services amid Brexit staff exodus